TARGETING NOTCH AND PLK1 IN HUMAN B-ALL: A NOVEL TUMOR SUPPRESSING MECHANISM AND A THERAPEUTIC TARGET.

被引:0
|
作者
Kannan, Sankar [1 ]
Golfman, Leonard [1 ]
Hall, Mandy [1 ]
Zweidler-McKay, Patrick [1 ]
机构
[1] UT MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1 / S2
页数:2
相关论文
共 38 条
  • [1] NOTCH AND PLK1: TARGETING NOVEL MECHANISMS IN B-ALL
    Zweidler-McKay, Patrick
    Kannan, Sankaranarayanan
    Fang, Wendy
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 922 - 922
  • [2] Notch Signaling In B-ALL Reveals PLK1 As A Potential Therapeutic Target In B-ALL: PLK1-Selective Inhibitor Poloxin Modulates Cyclin B and P53 Pathways, Leading To Growth Arrest and Apoptosis
    Kannan, Sankaranarayanan
    Hall, Mandy A.
    Golfman, Leonard S.
    Zweidler-McKay, Patrick A.
    BLOOD, 2013, 122 (21)
  • [3] Notch/HES1 Signaling Stabilizes p53 Expression Via a Novel PARP1-Chfr-PLK1-Mediated Mechanism in B-ALL
    Kannan, Sankaranarayanan
    Zweidler-McKay, Patrick A.
    BLOOD, 2012, 120 (21)
  • [4] Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma
    Duan, Zhenfeng
    Ji, Diana
    Weinstein, Edward
    Choy, Edwin
    Yang, Cao
    Mankin, Henry
    Hornicek, Francis
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [5] Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma
    Duan, Zhenfeng
    Ji, Diana
    Weinstein, Edward J.
    Liu, Xianzhe
    Susa, Michiro
    Choy, Edwin
    Yang, Cao
    Mankin, Henry
    Hornicek, Francis J.
    CANCER LETTERS, 2010, 293 (02) : 220 - 229
  • [6] Multiple Mechanisms of Notch-Mediated B-ALL Growth Arrest Via HES1 and PLK1: KIF11, CyclinB and p53
    Kannan, Sankaranarayanan
    Fang, Wendy
    Zweidler-McKay, Patrick
    BLOOD, 2010, 116 (21) : 1292 - 1293
  • [7] DYRK1A Is a Therapeutic Target in B-ALL in Children with Down Syndrome
    Lee, Paul
    Bhansali, Rahul
    Rammohan, Malini
    Hijiya, Nobuko
    Izraeli, Shai
    Bourquin, Jean-Pierre
    Malinge, Sebastien
    Crispino, John
    BLOOD, 2016, 128 (22)
  • [8] Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters
    Shin, Sol-Bi
    Kim, Dae-Hoon
    Kim, Da-Eun
    Aldonza, Mark Borris D.
    Kim, Yoosik
    Yim, Hyungshin
    CANCERS, 2021, 13 (17)
  • [9] STAT3 Is Activated By DYRK1A and Is a Potential Therapeutic Target in B-ALL
    Rammohan, Malini
    Bhansali, Rahul S.
    Tsai, Yi-Chien
    Dong, Alexander
    Malinge, Sebastien
    Bourquin, Jean-Pierre
    Crispino, John D.
    BLOOD, 2018, 132
  • [10] MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/-catenin pathway by suppressing DKK3
    Kong, Desheng
    Zhao, Linlin
    Sun, Lili
    Fan, Shengjin
    Li, Huibo
    Zhao, Yanqiu
    Guo, Zhibo
    Lin, Leilei
    Cui, Lin
    Wang, Ke
    Chen, Wenjia
    Zhang, Yihui
    Zhou, Jin
    Li, Yinghua
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (07) : 3627 - 3637